| Reported | Recall | Class | Product | Firm |
|---|
| 2023-08-02 | D-0940-2023 | Class II | Methylphenidate Hydrochloride Tablets | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-08-02 | D-0941-2023 | Class II | Diclofenac Sodium Topical Solution USP | ALEMBIC PHARMACEUTICALS, INC. |
| 2023-08-02 | D-0942-2023 | Class II | Safe Tussin DM Cough + Chest Congestion | Kramer Laboratories, Inc. |
| 2023-08-02 | D-0943-2023 | Class II | Safe Tussin PM Night Time Cough Relief | Kramer Laboratories, Inc. |
| 2023-08-02 | D-0944-2023 | Class II | Testosterone Cypionate-Testosterone Propionate 180-20 mg/mL in… | New Vitalis Pharmacy LLC dba New Vitalis Pharmacy |
| 2023-08-02 | D-0945-2023 | Class II | FentaNYL 500 mcg/250 mL | SCA Pharmaceuticals |
| 2023-07-26 | D-0923-2023 | Class II | Tizanidine Tablets USP | Dr Reddy's Laboratories Limited |
| 2023-07-26 | D-0924-2023 | Class III | Loteprednol Etabonate Ophthalmic Suspension | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-07-26 | D-0925-2023 | Class II | Fingolimod Capsules | Ascend Laboratories, LLC |
| 2023-07-26 | D-0926-2023 | Class II | SUCCINYLcholine Chloride 200 mg/10mL | New England Life Care, Inc. dba Advanced Compounding Solutions |
| 2023-07-26 | D-0927-2023 | Class II | PHENYLephrine HCl 10mg added to 0 | New England Life Care, Inc. dba Advanced Compounding Solutions |
| 2023-07-26 | D-0928-2023 | Class II | ROcuronium Bromide 50 mg/5 mL | New England Life Care, Inc. dba Advanced Compounding Solutions |
| 2023-07-26 | D-0929-2023 | Class II | Vancomycin HCl 1 | New England Life Care, Inc. dba Advanced Compounding Solutions |
| 2023-07-26 | D-0930-2023 | Class II | Sodium Bicarbonate in 5% Dextrose Injection | SterRx, LLC |
| 2023-07-26 | D-0931-2023 | Class II | Norepinephrine 4 mg per 250 mL | SterRx, LLC |
| 2023-07-26 | D-0932-2023 | Class II | Norepinephrine 8 mg per 250 mL | SterRx, LLC |
| 2023-07-26 | D-0933-2023 | Class II | Norepinephrine 16 mg per 250 mL | SterRx, LLC |
| 2023-07-26 | D-0934-2023 | Class II | Norepinephrine 32 mg per 250 mL | SterRx, LLC |
| 2023-07-26 | D-0939-2023 | Class II | Famotidine Tablets | Glenmark Therapeutics, Inc. |
| 2023-07-19 | D-0896-2023 | Class III | PANCREAZE | Vivus, Inc. |
| 2023-07-19 | D-0897-2023 | Class II | Original Eye Drops | K.C. Pharmaceuticals, Inc |
| 2023-07-19 | D-0898-2023 | Class II | Dry Eye Relief Lubricant Eye Drops | K.C. Pharmaceuticals, Inc |
| 2023-07-19 | D-0899-2023 | Class III | Amlodipine Besylate Tablets | Lupin Pharmaceuticals Inc. |
| 2023-07-19 | D-0900-2023 | Class II | Allergy | L. Perrigo Company |
| 2023-07-19 | D-0901-2023 | Class II | Non-Drowsy Allergy Relief | L. Perrigo Company |
| 2023-07-19 | D-0902-2023 | Class II | Allergy Relief | L. Perrigo Company |
| 2023-07-19 | D-0903-2023 | Class II | Allergy Relief | L. Perrigo Company |
| 2023-07-19 | D-0904-2023 | Class II | aller-ease | L. Perrigo Company |
| 2023-07-19 | D-0905-2023 | Class II | Allergy ALLER-FEX | L. Perrigo Company |
| 2023-07-19 | D-0906-2023 | Class II | allergy relief | L. Perrigo Company |
| 2023-07-19 | D-0907-2023 | Class II | Fexofenadine Hydrochloride Tablets | L. Perrigo Company |
| 2023-07-19 | D-0908-2023 | Class II | Fexofenadine Hydrochloride Tablets | L. Perrigo Company |
| 2023-07-19 | D-0909-2023 | Class II | allergyrelief | L. Perrigo Company |
| 2023-07-19 | D-0910-2023 | Class II | allergy relief | L. Perrigo Company |
| 2023-07-19 | D-0911-2023 | Class II | Picnic | L. Perrigo Company |
| 2023-07-19 | D-0912-2023 | Class II | Allergy Relief | L. Perrigo Company |
| 2023-07-19 | D-0913-2023 | Class II | Sunitinib Malate Capsules | Teva Pharmaceuticals USA Inc |
| 2023-07-19 | D-0914-2023 | Class II | Tiagabine Hydrochloride Tablets | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-07-19 | D-0915-2023 | Class II | Big Machine Distillery Hand Sanitizer Non-Sterile Solution Alcohol… | Tenn South Distillery LLC dba Big Machine Distillery |
| 2023-07-19 | D-0916-2023 | Class II | 0 | B. Braun Medical Inc. |
| 2023-07-19 | D-0917-2023 | Class II | Atropine Sulfate Injection | Accord Healthcare, Inc. |
| 2023-07-19 | D-0918-2023 | Class II | Bivalirudin for Injection 250 mg | Accord Healthcare, Inc. |
| 2023-07-19 | D-0919-2023 | Class I | Artificial Tears | Global Pharma Healthcare Private Limited |
| 2023-07-19 | D-0920-2023 | Class II | Artificial Tears | Global Pharma Healthcare Private Limited |
| 2023-07-19 | D-0921-2023 | Class I | Delsam Pharma's ARTIFICIAL TEARS | Global Pharma Healthcare Private Limited |
| 2023-07-19 | D-0922-2023 | Class II | Delsam Pharma's ARTIFICIAL TEARS | Global Pharma Healthcare Private Limited |
| 2023-07-19 | D-0938-2023 | Class I | Albuterol Sulfate Inhalation Aerosol | Cipla USA, Inc. |
| 2023-07-12 | D-0892-2023 | Class II | Tizanidine Tablets | Amerisource Health Services LLC |
| 2023-07-12 | D-0894-2023 | Class II | Tizanidine Hydrochloride Tablet 4mg | Preferred Pharmaceuticals, Inc. |
| 2023-07-12 | D-0895-2023 | Class II | Losartan Potassium Tablets | Strides Pharma Inc. |
| 2023-07-05 | D-0878-2023 | Class II | Tramadol Hydrochloride Tablets | The Harvard Drug Group |
| 2023-07-05 | D-0879-2023 | Class II | Endometrin | Ferring Pharmaceuticals Inc |
| 2023-07-05 | D-0880-2023 | Class II | Kanjo Homeopathic Pain Relief Cream With Arnica | Homeocare Laboratories, Inc. |
| 2023-07-05 | D-0881-2023 | Class II | Arnica 7 Cream | Homeocare Laboratories, Inc. |
| 2023-07-05 | D-0882-2023 | Class II | Bebelyn Colic Drops Homeopathic Remedy | Homeocare Laboratories, Inc. |
| 2023-07-05 | D-0883-2023 | Class II | Babelyn Diarrhea Drops Homeopathic Remedy | Homeocare Laboratories, Inc. |
| 2023-07-05 | D-0884-2023 | Class II | DoloEar Earache Drops | Homeocare Laboratories, Inc. |
| 2023-07-05 | D-0885-2023 | Class II | SnoreStop Naso Spray Bulk | Homeocare Laboratories, Inc. |
| 2023-07-05 | D-0886-2023 | Class II | StellaLife VEGA Oral Care Rinse | Homeocare Laboratories, Inc. |
| 2023-07-05 | D-0887-2023 | Class II | StellaLife VEGA Oral Care Rinse | Homeocare Laboratories, Inc. |
| 2023-07-05 | D-0888-2023 | Class II | StellaLife VEGA Oral Care Spray | Homeocare Laboratories, Inc. |
| 2023-07-05 | D-0889-2023 | Class II | StellaLife VEGA Oral Care Gel | Homeocare Laboratories, Inc. |
| 2023-07-05 | D-0890-2023 | Class II | StellaLife VEGA Oral Care Gel | Homeocare Laboratories, Inc. |
| 2023-07-05 | D-0891-2023 | Class II | Amphotericin B Liposome for Injection | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-06-28 | D-0877-2023 | Class III | Glycopyrrolate Tablets | Aurolife Pharma, LLC |
| 2023-06-28 | D-0893-2023 | Class I | ZIPRASIDONE HYDROCHLORIDE CAPSULES 20 mg | The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories |
| 2023-06-21 | D-0871-2023 | Class III | Lysteda | Amring Pharmaceuticals Inc |
| 2023-06-21 | D-0872-2023 | Class II | Isopropyl Alcohol Antiseptic 75% | Jarman's Midwest Cleaning Systems, Inc. |
| 2023-06-21 | D-0873-2023 | Class I | Alcohol Antiseptic 80% | Jarman's Midwest Cleaning Systems, Inc. |
| 2023-06-21 | D-0874-2023 | Class I | SOFT HANDS Alcohol Antiseptic 80% | Jarman's Midwest Cleaning Systems, Inc. |
| 2023-06-21 | D-0875-2023 | Class III | Tranexamic Acid USP Tablets | AVKARE LLC |
| 2023-06-21 | D-0876-2023 | Class II | Extended Phenytoin Sodium Capsules | Amneal Pharmaceuticals of New York, LLC |
| 2023-06-14 | D-0865-2023 | Class II | ASCORBIC ACID PRESERVED INJECTION SOLUTION | Empower Clinic Services LLC dba Empower Pharmacy |
| 2023-06-14 | D-0866-2023 | Class II | Levsin injection | Viatris Inc |
| 2023-06-14 | D-0867-2023 | Class II | Travoprost Ophthalmic Solution | Golden State Medical Supply Inc. |
| 2023-06-14 | D-0869-2023 | Class II | Buprenorphine Sublingual Tablets | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-06-14 | D-0870-2023 | Class III | GLYCOPYRROLATE INJECTION | HF Acquisition Co LLC |
| 2023-06-07 | D-0772-2023 | Class II | Safe tussin DM | Denison Pharmaceuticals, LLC |
| 2023-06-07 | D-0773-2023 | Class II | Colic Calm | Denison Pharmaceuticals, LLC |
| 2023-06-07 | D-0774-2023 | Class II | Pin-Away PYRENTAL PAMOATE | Denison Pharmaceuticals, LLC |
| 2023-06-07 | D-0775-2023 | Class II | Safe tussin PM | Denison Pharmaceuticals, LLC |
| 2023-06-07 | D-0776-2023 | Class II | HYDROmorphone HCl 10 mg in 0 | SSM Health Care St. Louis DBA SSM St. Clare Health Center |
| 2023-06-07 | D-0777-2023 | Class II | Sodium Chloride 0 | Fresenius Medical Care Holdings, Inc. |
| 2023-06-07 | D-0778-2023 | Class III | Phenylephrine HCl 20 mg added to 0 | New England Life Care, Inc. dba Advanced Compounding Solutions |
| 2023-06-07 | D-0779-2023 | Class II | Atropine Sulfate Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0780-2023 | Class II | Acetaminophen & Codeine Phosphate Oral Solution 120mg/12mg/5mL | Akorn, Inc. |
| 2023-06-07 | D-0781-2023 | Class II | Acetic Acid Otic Solution | Akorn, Inc. |
| 2023-06-07 | D-0782-2023 | Class II | Acyclovir Oral Suspension | Akorn, Inc. |
| 2023-06-07 | D-0783-2023 | Class II | Albuterol Sulfate Syrup | Akorn, Inc. |
| 2023-06-07 | D-0784-2023 | Class II | Apraclonidine Ophthalmic Solution 0 | Akorn, Inc. |
| 2023-06-07 | D-0785-2023 | Class II | Artificial Tears Solution | Akorn, Inc. |
| 2023-06-07 | D-0786-2023 | Class II | Artificial Tears Ointment | Akorn, Inc. |
| 2023-06-07 | D-0787-2023 | Class II | Azelastine Hydrochloride Nasal Spray | Akorn, Inc. |
| 2023-06-07 | D-0788-2023 | Class II | AK-POLY-BAC | Akorn, Inc. |
| 2023-06-07 | D-0789-2023 | Class II | Calcipotriene Topical Solution | Akorn, Inc. |
| 2023-06-07 | D-0790-2023 | Class II | Calcitriol Injection 1 mcg/mL | Akorn, Inc. |
| 2023-06-07 | D-0791-2023 | Class II | Cetrorelix Acetate for Injection | Akorn, Inc. |
| 2023-06-07 | D-0792-2023 | Class II | Ciclopirox Topical Solution 8% | Akorn, Inc. |
| 2023-06-07 | D-0793-2023 | Class II | Cimetidine HCl Oral Solution 300mg/5mL | Akorn, Inc. |
| 2023-06-07 | D-0794-2023 | Class II | Clobetasol Propionate Cream | Akorn, Inc. |
| 2023-06-07 | D-0795-2023 | Class II | Clobetasol Propionate Ointment | Akorn, Inc. |
| 2023-06-07 | D-0796-2023 | Class II | Clobetasol Propionate Shampoo | Akorn, Inc. |
| 2023-06-07 | D-0797-2023 | Class II | Cromolyn Sodium Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0798-2023 | Class II | DetomiSed | Akorn, Inc. |
| 2023-06-07 | D-0799-2023 | Class II | Dicyclomine Hydrochloride Injection USP | Akorn, Inc. |
| 2023-06-07 | D-0800-2023 | Class II | Diuril | Akorn, Inc. |
| 2023-06-07 | D-0801-2023 | Class II | DOCU LIQUID | Akorn, Inc. |
| 2023-06-07 | D-0802-2023 | Class II | Ephedrine Sulfate Injection | Akorn, Inc. |
| 2023-06-07 | D-0803-2023 | Class II | Ferrous Sulfate Iron Supplement Drops | Akorn, Inc. |
| 2023-06-07 | D-0804-2023 | Class II | Fluticasone Propionate Nasal Spray | Akorn, Inc. |
| 2023-06-07 | D-0805-2023 | Class II | Gonak Hypromellose Ophthalmic Solution 25mg/mL | Akorn, Inc. |
| 2023-06-07 | D-0806-2023 | Class II | Granisetron HCl Injection | Akorn, Inc. |
| 2023-06-07 | D-0807-2023 | Class II | Guaiatussin AC Sugar-Free | Akorn, Inc. |
| 2023-06-07 | D-0808-2023 | Class II | Guaifenesin Oral Solution | Akorn, Inc. |
| 2023-06-07 | D-0809-2023 | Class II | HydrALAZINE HCl Injection | Akorn, Inc. |
| 2023-06-07 | D-0810-2023 | Class II | Hydrocortisone and Acetic Acid Otic Solution | Akorn, Inc. |
| 2023-06-07 | D-0811-2023 | Class II | Hydromorphone Hydrochloride Injection | Akorn, Inc. |
| 2023-06-07 | D-0812-2023 | Class II | IC-Green | Akorn, Inc. |
| 2023-06-07 | D-0813-2023 | Class II | Ketorolac Tromethamine Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0814-2023 | Class II | Lactulose Solution | Akorn, Inc. |
| 2023-06-07 | D-0815-2023 | Class II | Lactulose Solution | Akorn, Inc. |
| 2023-06-07 | D-0816-2023 | Class II | Levetiracetam Oral Solution 100 mg/mL | Akorn, Inc. |
| 2023-06-07 | D-0817-2023 | Class II | Levocarnitine Oral Solution | Akorn, Inc. |
| 2023-06-07 | D-0818-2023 | Class II | Levofloxacin Injection 500mg/20 mL | Akorn, Inc. |
| 2023-06-07 | D-0819-2023 | Class II | Levofloxacin Oral Solution | Akorn, Inc. |
| 2023-06-07 | D-0820-2023 | Class II | Levofloxacin Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0821-2023 | Class II | Lidocaine 2 | Akorn, Inc. |
| 2023-06-07 | D-0822-2023 | Class II | Lidocaine Ointment USP | Akorn, Inc. |
| 2023-06-07 | D-0823-2023 | Class II | Lidocaine HCl Jelly USP | Akorn, Inc. |
| 2023-06-07 | D-0824-2023 | Class II | Lidocaine Hydrochloride Oral Topical Solution | Akorn, Inc. |
| 2023-06-07 | D-0825-2023 | Class II | Lorazepam Injection | Akorn, Inc. |
| 2023-06-07 | D-0826-2023 | Class II | Lorazepam Oral Concentrate | Akorn, Inc. |
| 2023-06-07 | D-0827-2023 | Class II | Megestrol Acetate Oral Suspension | Akorn, Inc. |
| 2023-06-07 | D-0828-2023 | Class II | Midazolam Injection | Akorn, Inc. |
| 2023-06-07 | D-0829-2023 | Class II | Moxifloxacin HCl Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0830-2023 | Class II | Naloxone Injection | Akorn, Inc. |
| 2023-06-07 | D-0831-2023 | Class II | Neomycin & Polymyxin B Sulfates | Akorn, Inc. |
| 2023-06-07 | D-0832-2023 | Class II | Olopatadine HCl Nasal Spray | Akorn, Inc. |
| 2023-06-07 | D-0833-2023 | Class II | Olopatadine HCl Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0834-2023 | Class II | Oxcarbazepine Oral Suspension | Akorn, Inc. |
| 2023-06-07 | D-0835-2023 | Class II | Pilocarpine Hydrochloride Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0836-2023 | Class II | Prednisolone Oral Solution | Akorn, Inc. |
| 2023-06-07 | D-0837-2023 | Class II | Promethazine HCl & Codeine Phosphate Oral Solution | Akorn, Inc. |
| 2023-06-07 | D-0838-2023 | Class II | Promethazine HCl Oral Solution | Akorn, Inc. |
| 2023-06-07 | D-0839-2023 | Class II | Proparacaine HCl Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0840-2023 | Class II | Rifampin Capsules USP | Akorn, Inc. |
| 2023-06-07 | D-0841-2023 | Class II | Rifampin Capsules USP | Akorn, Inc. |
| 2023-06-07 | D-0842-2023 | Class II | Ropivacaine Hydrochloride Injection USP | Akorn, Inc. |
| 2023-06-07 | D-0843-2023 | Class II | Fentanyl Citrate Injection | Akorn, Inc. |
| 2023-06-07 | D-0844-2023 | Class II | Sodium Chloride Ophthalmic Ointment | Akorn, Inc. |
| 2023-06-07 | D-0845-2023 | Class II | Sodium Chloride Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0846-2023 | Class II | Sodium DIURIL | Akorn, Inc. |
| 2023-06-07 | D-0847-2023 | Class II | Sufenta | Akorn, Inc. |
| 2023-06-07 | D-0848-2023 | Class II | Sulfamethoxazole & Trimethoprim Oral Suspension USP | Akorn, Inc. |
| 2023-06-07 | D-0849-2023 | Class II | Timolol Maleate Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0850-2023 | Class II | Tobramycin Inhalation Solution USP | Akorn, Inc. |
| 2023-06-07 | D-0851-2023 | Class II | Tobramycin Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0852-2023 | Class II | Trihexyphenidyl Hydrochloride Oral Solution | Akorn, Inc. |
| 2023-06-07 | D-0853-2023 | Class II | Tropicamide Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0854-2023 | Class II | Valproic Acid Oral Solution | Akorn, Inc. |
| 2023-06-07 | D-0855-2023 | Class II | Vitamin D Supplement Drops | Akorn, Inc. |
| 2023-06-07 | D-0856-2023 | Class II | XOPENEX | Akorn, Inc. |
| 2023-06-07 | D-0857-2023 | Class II | Amantadine Hydrochloride Oral Solution USP | Akorn, Inc. |
| 2023-06-07 | D-0858-2023 | Class II | Calcitriol Injection 2 mcg/mL | Akorn, Inc. |
| 2023-06-07 | D-0859-2023 | Class II | Midazolam Injection | Akorn, Inc. |
| 2023-06-07 | D-0860-2023 | Class II | Olopatadine HCl Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0861-2023 | Class II | Pilocarpine Hydrochloride Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0862-2023 | Class II | Pilocarpine Hydrochloride Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0863-2023 | Class II | Ropivacaine Hydrochloride Injection USP | Akorn, Inc. |
| 2023-06-07 | D-0864-2023 | Class II | Tropicamide Ophthalmic Solution | Akorn, Inc. |
| 2023-06-07 | D-0868-2023 | Class I | G-Supress DX | Novis PR, LLC dba Kramer Novis |
| 2023-05-31 | D-0648-2023 | Class II | Microplegia | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0649-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0650-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0651-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0652-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0653-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0654-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0655-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0656-2023 | Class II | Microplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0657-2023 | Class II | Transplant Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0658-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0659-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0660-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0661-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0662-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0663-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0664-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0665-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0666-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0667-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0668-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0669-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0670-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0671-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0672-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0673-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0674-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0675-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |
| 2023-05-31 | D-0676-2023 | Class II | Cardioplegia Solution | Central Admixture Pharmacy Services, Inc. |